People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become an insulin-free alternative to stop, prevent, and potentially cure this chronic disease.
Type 1 diabetes is an autoimmune disease where the insulin-producing beta cells in the pancreas are wrongly detected as foreign and destroyed by the immune system.
“There is no cure; once initiated, the disease will progress to complete destruction of the insulin-producing cells of the pancreas,” Pierre Vandepapelière, CEO of Imcyse, told me. This Belgian company is developing an innovative form of treatment that could change the way type 1 diabetes is treated.
Continue –> Labiotech.eu
